Announcements Trials

Browse Landscape

Phase

Status

Completed 26 Terminated 7 Active not recruiting 7 Withdrawn 5 Recruiting 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Transitional Cell 1

Interventions

Cisplatin 517 Radiotherapy 378 Cyclophosphamide 368 Carboplatin 359 Capecitabine 342 Paclitaxel 337 Oxaliplatin 336 Gemcitabine 322 Docetaxel 317 Fluorouracil 290 Drug Therapy 276 Bevacizumab 248 apatinib 247 camrelizumab 219 Etoposide 201 Irinotecan 182 Doxorubicin 181 Leucovorin 163 Dexamethasone 161 pembrolizumab 153 Neoadjuvant Therapy 146 sintilimab 145 anlotinib 140 Blood Specimen Collection 140 Pemetrexed 138 Cytarabine 138 toripalimab 133 Surgical Procedures, Operative 131 Radiosurgery 131 S 1 (combination) 125

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × sapanisertib × Clear all

NCT03745911 2018-11-19

Paclitaxel and TAK-228 in Urothelial Carcinoma

Associació per a la Recerca Oncologica, Spain

Phase 2 Unknown

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡